ViewRay (VRAYQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOptions ChainSEC FilingsTrends VRAYQ vs. GMVDF, AHPI, NMRD, MOTS, BRSH, DRTSW, ANZUW, BBLGW, BRSHW, and GMVDWShould you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include G Medical Innovations (GMVDF), Allied Healthcare Products (AHPI), Nemaura Medical (NMRD), Motus GI (MOTS), Bruush Oral Care (BRSH), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), and G Medical Innovations (GMVDW). These companies are all part of the "medical equipment" industry. ViewRay vs. G Medical Innovations Allied Healthcare Products Nemaura Medical Motus GI Bruush Oral Care Alpha Tau Medical Anzu Special Acquisition Corp I Bone Biologics Bruush Oral Care G Medical Innovations ViewRay (NASDAQ:VRAYQ) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, valuation, risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and media sentiment. Does the MarketBeat Community believe in VRAYQ or GMVDF? ViewRay and G Medical Innovations both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformViewRayN/AN/AG Medical InnovationsN/AN/A Which has stronger valuation & earnings, VRAYQ or GMVDF? G Medical Innovations has lower revenue, but higher earnings than ViewRay. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViewRay$102.21M0.00-$107.33MN/AN/AG Medical Innovations$4.42M0.00-$24.63MN/AN/A Is VRAYQ or GMVDF more profitable? Company Net Margins Return on Equity Return on Assets ViewRayN/A N/A N/A G Medical Innovations N/A N/A N/A Does the media prefer VRAYQ or GMVDF? In the previous week, G Medical Innovations had 1 more articles in the media than ViewRay. MarketBeat recorded 1 mentions for G Medical Innovations and 0 mentions for ViewRay. ViewRay's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score. Company Overall Sentiment ViewRay Neutral G Medical Innovations Neutral Which has more risk & volatility, VRAYQ or GMVDF? ViewRay has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Comparatively, G Medical Innovations has a beta of 2.69, suggesting that its stock price is 169% more volatile than the S&P 500. Do insiders and institutionals have more ownership in VRAYQ or GMVDF? 15.5% of ViewRay shares are owned by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are owned by institutional investors. 2.5% of ViewRay shares are owned by insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryG Medical Innovations beats ViewRay on 4 of the 6 factors compared between the two stocks. Ad Crypto 101 MediaDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! Get ViewRay News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart VRAYQ vs. The Competition Export to ExcelMetricViewRayElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$18,000.00$3.57B$5.17B$8.94BDividend YieldN/A1.61%5.04%4.03%P/E RatioN/A16.42108.3116.26Price / SalesN/A92.931,297.7492.29Price / CashN/A50.9739.4636.42Price / BookN/A3.736.435.98Net Income-$107.33M$89.83M$115.02M$225.08M ViewRay Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRAYQViewRayN/AN/AN/AN/A$18,000.00$102.21M0.00300GMVDFG Medical InnovationsN/AN/AN/AN/A$26,000.00$4.42M0.0072AHPIAllied Healthcare ProductsN/AN/AN/AN/A$16,000.00$27.05M0.00150Analyst ForecastNMRDNemaura MedicalN/A$0.00flatN/AN/A$8,000.00$80,000.000.0040MOTSMotus GIN/A$0.00flatN/A-100.0%$2,000.00$320,000.000.0030BRSHBruush Oral CareN/A$0.00flatN/A-99.3%$1,000.00$2.92M0.0011Gap UpDRTSWAlpha Tau MedicalN/A$0.20flatN/AN/A$0.00N/A0.0080News CoverageANZUWAnzu Special Acquisition Corp IN/A$0.09flatN/AN/A$0.00N/A0.002BBLGWBone BiologicsN/A$28.49flatN/A+641.9%$0.00N/A0.002Positive NewsGap DownBRSHWBruush Oral CareN/A$0.01flatN/AN/A$0.00$2.92M0.0011GMVDWG Medical InnovationsN/A$0.02flatN/AN/A$0.00$4.42M0.0072News Coverage Related Companies and Tools Related Companies G Medical Innovations Alternatives Allied Healthcare Products Alternatives Nemaura Medical Alternatives Motus GI Alternatives Bruush Oral Care Alternatives Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Bone Biologics Alternatives Bruush Oral Care Alternatives G Medical Innovations Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VRAYQ) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredIs Your 401(k) Safe? The Real Risk No One Sees ComingEvery day you wait, your savings are at greater risk. The government isn't slowing down, inflation isn't stopp...Golden Crest | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViewRay, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViewRay With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
